Yoon Seoyoung, Park Tae Sung, Kim Nam Kyu, Lee Kyung-A, Kim Juwon, Song Jaewoo, Kim Bo-Young, Choi Jong Rak
Department of Laboratory Medicine, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul 120-752, Korea.
Cancer Genet Cytogenet. 2009 Jan 15;188(2):61-4. doi: 10.1016/j.cancergencyto.2008.09.001.
Hereditary nonpolyposis colorectal cancer (HNPCC) (MIM #114500), also called Lynch syndrome, is an autosomal dominantly inherited cancer syndrome accounting for 1-5% of all colorectal cancer cases. In a study of three Korean families with HNPCC consistent with the revised Bethesda criteria, DNA testing revealed three novel HNPCC germline mutations in two genes: namely, MLH1, with an insertion resulting in a frameshift and a premature stop codon; MSH2, with a deletion at nucleotide 633, exon 3, which results in stop of translation at codon 213; and MSH2, with a deletion at nucleotide 1413, exon 9, resulting in a frameshift and a premature stop codon. In the first two families, there were splice mutations at c.2006-6 thymine to cytosine. The clinical implications of a frameshift mutation are discussed, along with the significance of common underlying splice mutations existing within families with HNPCC.
遗传性非息肉病性结直肠癌(HNPCC)(MIM #114500),也称为林奇综合征,是一种常染色体显性遗传的癌症综合征,占所有结直肠癌病例的1%至5%。在一项针对三个符合修订后的贝塞斯达标准的韩国HNPCC家族的研究中,DNA检测在两个基因中发现了三个新的HNPCC种系突变:即MLH1基因,有一个插入导致移码和提前终止密码子;MSH2基因,在第3外显子的633位核苷酸处有一个缺失,导致在第213密码子处停止翻译;以及MSH2基因,在第9外显子的1413位核苷酸处有一个缺失,导致移码和提前终止密码子。在前两个家族中,存在c.2006-6处胸腺嘧啶到胞嘧啶的剪接突变。文中讨论了移码突变的临床意义,以及HNPCC家族中存在的常见潜在剪接突变的重要性。